Drugs / Astrazeneca/Oxford Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04885764 | Feb → Oct 2021 | COVID-19 | Ain Shams University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Astrazeneca/Oxford Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04885764 ↗ |
| Modality | Vaccine | “Viral non replicated vector vaccine” NCT04885764 ↗ |
| Route | Intramuscular | “given Intramuscular injection” NCT04885764 ↗ |